Table IV.

Two-sided t-tests analyses for secondary outcomes functional capacity and health-related quality of life

Item		IG				CG				p-value	SES (95% CI)
		n	M	MD	SD	n	M	MD	SD
HFAQ functional capacity
HFAQ_T0	Baseline	139	65.02	66.67	17.22	141	68.23	70.83	19.22	0.142	0.18 (–0.06 – 0.41)
HFAQ_T1	4 weeks	135	81.91	87.50	16.93	130	78.97	83.33	20.97	0.210	0.16 (–0.40 – 0.09)
HFAQ_T2	12 months	111	85.81	91.67	19.58	103	80.50	87.50	19.29	0.047*	0.27 (–0.54 – 0.00)
Health-related quality of life
EQ5D Index_T0	Baseline	147	0.72	0.79	0.19	137	0.74	0.80	0.18	0.607	0.06 (–0.17 – 0.29)
EQ5D Index_T1	4 weeks	140	0.85	0.89	0.13	134	0.82	0.88	0.17	0.094	0.21 (–0.44 – 0.03)
EQ5D Index_T2	12 months	113	0.85	0.94	0.21	103	0.82	0.88	0.19	0.293	0.41 (–0.41 – 0.12)
VA scale
VA-Scale_T0	Baseline	149	57.50	60	15.90	143	57.61	60	16.28	0.956	0.01 (–0.22 – 0.24)
VA-Scale_T1	4 Weeks	146	73.94	80	17.61	140	70.46	75	20.47	0.125	0.18 (–0.42 – 0.05)
VA-Scale_T2	12 Months	117	75.79	80	19.04	103	71.16	75	17.80	0.065	0.25 (–0.52 – 0.02)

IG: intervention group; CG: control group; SES: standardised effect size Cohen’s d; 95% CI: 95% confidence interval; HFAQ: Hannover Functional Ability Questionnaire (value range 0–100); HRQoL: health-related quality of life (EQ-5D-5L); VA scale: visual analogue scale (EQ VAS); M: mean; SD: standard deviation; MD: median;

^*p < 0.05.